Cite
HARVARD Citation
Sabbagh, M. et al. (n.d.). P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics. Alzheimer's & dementia. p. P285. [Online].